Vi bruger cookies på accura.dk

accura.dk anvender cookies for at forbedre brugervenligheden og funktionaliteten. Når du benytter sitet, samtykker du til vores anvendelse af cookies. Læs mere om cookies på accura.dk. God fornøjelse.

Læs mere om vores cookie-politik og få vejledning til at slette cookies

IPR & Life Science Newsletter

June 2019: In this edition of Accura’s IPR & Life Science News, we update you on the new harmonized procedure for trademarks for medicinal cannabis – a welcome update considering the increased number of trademark applications containing the word cannabis. Further, we update you on the findings of a study
conducted by the EPO & EUIPO with some interesting results that strongly highlight the importance of IPR in
a commercial context. Open newsletter.

May 2019: Update yourself on the recent developments within the regulation of medicinal cannabis in Denmark. Further, a number of key provisions from the newly adopted EU Directive on Copyright are points of discussion. Open newsletter.

February 2019: In this edition we update you on the most recent expansions of the Danish pilot programme on medicinal cannabis, including the possibilities for export. You can also read the third part of Accura’s series on trade secrets dealing with unintentional use, acquisition or disclosure of trade secrets. Finally, Accura comments on the much discussed BIG MAC decision from EUIPO. Open newsletter.

December 2018: In this edition we update you on the new Danish Trademarks Act entering into force on 1 January 2019. You can also read about the latest European developments with regards to patentability of AI and machine learning inventions as well as the ECJ’s decision to deny SPC-protection of CE marked medical devices comprising a pharmaceutical drug. Finally, we provide you with the second article in our series on the regulation of trade secrets; this time focusing on enforcement options. Open newsletter.

November 2018: In this edition we start a series of articles on the regulation of trade secrets. Also, update yourself on important news on European and Danish law vital to the sale of medicines: The fight against falsified medicines and perhaps a brand new pricing regime in Denmark. Open newsletter.

August 2018: Read about two significant new developments in European patent law on SPCs. Also, get updated on the topics of influencer marketing and online posting of photographs. Open newsletter.

April 2018: World IP Day-edition. Learn about two key judgments fro the CJEU; one regarding EU design law and the other on the interplay between the regulatory framework for placing medicinal products on the market and EU competition law. Open newsletter.

March 2018: An overview of the Danish government’s brand new Life Science Growth Plan, and important news on confidentiality between patent attorneys and their clients. Open newsletter.

February 2018: A broad range of topics, from a controversial new pilot programme on medicinal cannabis over key European case law on both transparency of clinical data and fraudulent trademark invoices, the Danish court system going fully digital, and important new guidelines significantly altering how to offer professionally relevant courses and congresses to Danish healthcare professionals. Open newsletter.

January 2018: How IoT and the UPC bring about significant new developments in European patent law, and new Danish rules on OTC pharma. Open newsletter.

November 2017: The important provisional measures such as preliminary injunctions before the UPC, Accura's practical Quick guide to proper use of trademarks and information on the Danish Medicines Council's newly adopted and faster process for assessment of medicinal products without added clinical value. Open newsletter.

October 2017: The procedures of litigation before the UPC, information on the improved options for registering motion marks and news on Thailand’s accession to the Madrid Protocol. Open newsletter.

August 2017: The Unified Patent Court and Guide on Pre-Launch of Medicines. Open newsletter.